Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjustments to Financial Statements: Removal of Goodwill
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The information presents a comparison between reported and adjusted financial figures for total assets and total shareholders’ investment over a five-year period. The adjustments appear to relate to the removal of goodwill and intangible assets, resulting in significantly lower adjusted values. A consistent pattern emerges where the adjusted figures are substantially smaller than the reported figures, and both exhibit growth over the period, though at differing rates.
- Total Assets
- Reported total assets decreased from US$75,196 million in 2021 to US$73,214 million in 2023, before increasing to US$81,414 million in 2024 and further to US$86,713 million in 2025. Adjusted total assets followed a similar trend, declining from US$51,965 million in 2021 to US$49,535 million in 2023, then rising to US$58,306 million in 2024 and US$62,678 million in 2025. The difference between reported and adjusted total assets remained substantial throughout the period, indicating a significant amount of goodwill and intangibles included in the reported figures.
- Shareholders’ Investment
- Reported total shareholders’ investment increased steadily from US$35,802 million in 2021 to US$52,130 million in 2025. Adjusted total shareholders’ investment also increased, but from a much lower base of US$12,571 million in 2021 to US$28,095 million in 2025. The gap between reported and adjusted shareholders’ investment widened over time, mirroring the trend observed with total assets. This suggests that the removal of goodwill and intangibles has a proportionally larger impact on the shareholders’ equity portion of the balance sheet.
The growth rate in adjusted figures, while positive, is consistently lower than the growth rate in reported figures. This implies that the growth observed in the reported financials is partially attributable to acquisitions or internally generated goodwill, which are excluded from the adjusted figures. The consistent difference between reported and adjusted values highlights the importance of understanding the composition of assets and equity when evaluating the company’s financial position. The adjustments suggest a more conservative view of the company’s net worth when goodwill and intangible assets are excluded.
- Magnitude of Adjustment
- In 2021, the difference between reported and adjusted total assets was approximately US$23,231 million. By 2025, this difference had grown to US$24,035 million. Similarly, the difference between reported and adjusted shareholders’ investment increased from US$23,231 million in 2021 to US$24,035 million in 2025. These increasing discrepancies indicate that the impact of goodwill and intangible assets on the reported financials is becoming more pronounced over time.
Abbott Laboratories, Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial metrics demonstrate a significant impact from adjusting for goodwill and intangible assets. Removing these items from the calculations results in substantially different performance indicators compared to the reported figures. Generally, the adjusted ratios reveal a stronger financial position and profitability, though trends vary across metrics.
- Total Asset Turnover
- The reported total asset turnover exhibits a slight decline from 0.57 in 2021 to 0.51 in 2025. However, the adjusted total asset turnover consistently remains higher, starting at 0.83 in 2021 and decreasing to 0.71 in 2025. This indicates that, excluding goodwill and intangibles, the company generates more revenue per dollar of assets. The adjusted ratio’s decline mirrors the reported ratio, suggesting the underlying operational efficiency trend is consistent regardless of goodwill treatment.
- Financial Leverage
- Reported financial leverage decreases steadily from 2.10 in 2021 to 1.66 in 2025, suggesting a reduction in the company’s reliance on debt financing relative to equity. The adjusted financial leverage is considerably higher, beginning at 4.13 in 2021 and falling to 2.23 in 2025. This substantial difference highlights the considerable contribution of debt financing to the acquisition of goodwill and intangible assets. The decreasing trend in the adjusted ratio suggests a lessening reliance on debt to fund these acquisitions over time.
- Return on Equity (ROE)
- Reported ROE fluctuates considerably, peaking at 28.12% in 2024 before declining to 12.51% in 2025. The adjusted ROE is markedly higher throughout the period, starting at 56.25% in 2021 and decreasing to 23.22% in 2025. This substantial difference underscores the impact of goodwill and intangibles on reported equity. The adjusted ROE’s decline suggests diminishing returns on equity when these items are excluded from the calculation. The 2024 peak in reported ROE is not mirrored in the adjusted ROE, indicating a significant contribution from goodwill or intangible asset gains in that year.
- Return on Assets (ROA)
- Reported ROA also demonstrates volatility, with a peak of 16.46% in 2024 and a subsequent drop to 7.52% in 2025. The adjusted ROA consistently exceeds the reported ROA, beginning at 13.61% in 2021 and decreasing to 10.41% in 2025. Similar to ROE, the adjusted ROA’s trend is less pronounced than the reported ROA, indicating that the impact of goodwill and intangibles is more significant on the reported asset base. The 2024 peak in reported ROA is not reflected in the adjusted ROA, suggesting gains related to goodwill or intangible assets contributed to the higher reported profitability.
In summary, adjusting for goodwill and intangible assets reveals a fundamentally different financial picture. The adjusted ratios consistently demonstrate higher levels of profitability and asset utilization, but also a greater degree of financial leverage. The trends observed in the adjusted ratios are generally more moderate than those in the reported ratios, suggesting that the inclusion of goodwill and intangibles introduces greater volatility into the reported financial performance.
Abbott Laboratories, Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= ÷ =
An examination of the financial information reveals trends in both total asset values and associated turnover ratios over a five-year period. Reported total assets experienced a slight decrease from 2021 to 2023, followed by increases in both 2024 and 2025. Adjusted total assets mirrored this pattern, with a more pronounced decrease between 2021 and 2023, and subsequent increases in the later years. However, the adjusted asset base consistently remained lower than the reported asset base throughout the period.
- Reported Total Asset Turnover
- The reported total asset turnover ratio exhibited a relatively stable, albeit slightly declining, trend. Beginning at 0.57 in 2021, the ratio increased to 0.59 in 2022 before decreasing to 0.55 in 2023. Further declines were observed in 2024 and 2025, reaching 0.52 and 0.51 respectively. This suggests a gradual reduction in the efficiency with which the company generates sales from its reported asset base.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio demonstrated a similar pattern to the reported ratio, but at a higher level. It started at 0.83 in 2021 and rose to 0.85 in 2022, then decreased to 0.81 in 2023. A more noticeable decline occurred in 2024, falling to 0.72, and continued to 0.71 in 2025. The consistently higher values of the adjusted ratio, compared to the reported ratio, indicate that excluding certain asset components results in a more favorable assessment of asset utilization efficiency.
The divergence between reported and adjusted asset turnover suggests that the components excluded from the adjusted asset base – likely including goodwill and intangible assets – are contributing to a lower overall turnover when considered in the reported figures. The declines observed in both ratios in the later years warrant further investigation to determine the underlying causes and potential implications for future performance.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Total Abbott shareholders’ investment
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Abbott shareholders’ investment
= ÷ =
An examination of the financial information reveals trends in both reported and adjusted asset and equity figures, impacting calculated financial leverage ratios over the five-year period. Reported total assets experienced a slight decrease between 2021 and 2023, followed by increases in 2024 and 2025. Conversely, adjusted total assets demonstrate a more pronounced decline from 2021 to 2023 before exhibiting growth in subsequent years, though remaining below the reported total asset values.
Similar patterns are observed in shareholders’ investment. Reported total shareholders’ investment consistently increased throughout the period, while adjusted total shareholders’ investment also rose, but at a slower pace initially, with a more substantial increase occurring between 2023 and 2025. The divergence between reported and adjusted figures suggests the presence of significant goodwill and intangible assets impacting the reported values.
- Reported Financial Leverage
- Reported financial leverage decreased steadily from 2.10 in 2021 to 1.66 in 2025. This indicates a decreasing reliance on total assets to finance shareholders’ investment when considering reported figures. The decline is relatively consistent year-over-year.
- Adjusted Financial Leverage
- Adjusted financial leverage exhibited a more volatile trend. It began at a substantially higher level of 4.13 in 2021 and decreased to 2.23 by 2025. The most significant reduction occurred between 2021 and 2023, followed by a more moderate decline. This suggests that the company’s leverage, when excluding the impact of goodwill and intangible assets, was considerably higher initially and has been reduced over time, though it remains elevated compared to the reported leverage ratio.
The substantial difference between reported and adjusted financial leverage highlights the considerable influence of goodwill and intangible assets on the company’s overall financial structure. The decreasing adjusted leverage suggests a deliberate effort, or natural progression, to reduce reliance on these assets relative to shareholders’ investment. The continued growth in reported assets and equity, coupled with decreasing reported leverage, indicates a strengthening financial position based on reported metrics. However, the adjusted figures provide a more conservative view of the company’s financial risk profile.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net earnings ÷ Total Abbott shareholders’ investment
= 100 × ÷ =
2 Adjusted ROE = 100 × Net earnings ÷ Adjusted total Abbott shareholders’ investment
= 100 × ÷ =
The period under review demonstrates significant fluctuations in both reported and adjusted shareholders’ investment, alongside corresponding shifts in return on equity. A notable divergence exists between the reported and adjusted ROE figures, suggesting a substantial impact from goodwill and intangible assets on the company’s overall profitability assessment.
- Shareholders’ Investment
- Reported total shareholders’ investment exhibits a consistent upward trend throughout the period, increasing from US$35,802 million in 2021 to US$52,130 million in 2025. However, the adjusted total shareholders’ investment, which presumably excludes the impact of goodwill and intangibles, shows a more moderate increase, rising from US$12,571 million to US$28,095 million over the same timeframe. The difference between the reported and adjusted figures widens considerably from 2023 onwards, indicating a growing proportion of shareholders’ investment tied up in these assets.
- Reported Return on Equity (ROE)
- Reported ROE experiences volatility. It declines from 19.75% in 2021 to 14.83% in 2023, then surges to 28.12% in 2024 before falling back to 12.51% in 2025. This fluctuation suggests the reported profitability is sensitive to changes in net income and shareholders’ equity, potentially influenced by accounting treatments related to goodwill and intangible assets.
- Adjusted Return on Equity (ROE)
- Adjusted ROE, calculated with the exclusion of goodwill and intangible assets, consistently remains higher than the reported ROE. It begins at 56.25% in 2021 and decreases to 38.35% in 2023, then increases sharply to 54.58% in 2024, before declining to 23.22% in 2025. This pattern indicates that the underlying operational profitability, excluding the effects of goodwill and intangibles, is considerably stronger than the reported figures suggest. The decline in adjusted ROE in 2025 mirrors the decline in reported ROE, but from a higher base.
The substantial difference between reported and adjusted ROE throughout the period highlights the significant influence of goodwill and intangible assets on the company’s reported financial performance. While reported ROE fluctuates, the consistently higher adjusted ROE suggests a robust underlying business profitability. The increasing gap between the two measures warrants further investigation into the nature and performance of these assets, as well as the accounting policies applied to them.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net earnings ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Net earnings ÷ Adjusted total assets
= 100 × ÷ =
The period under review demonstrates fluctuating performance when examining both reported and adjusted return on assets. Total assets, both reported and adjusted, exhibit varied movements over the five-year span. A significant divergence exists between the reported and adjusted asset figures, impacting the respective ROA calculations.
- Total Assets
- Reported total assets decreased from 2021 to 2023, declining from US$75,196 million to US$73,214 million. A substantial increase is then observed in 2024, reaching US$81,414 million, followed by further growth to US$86,713 million in 2025. Adjusted total assets follow a similar pattern of decline between 2021 and 2023, decreasing from US$51,965 million to US$49,535 million, before increasing to US$58,306 million in 2024 and US$62,678 million in 2025. The difference between reported and adjusted assets widens over time, suggesting a growing proportion of goodwill and intangible assets not included in the adjusted figures.
- Reported Return on Assets (ROA)
- Reported ROA remained relatively stable between 2021 and 2022, at 9.40% and 9.31% respectively. A decline to 7.82% is noted in 2023. However, 2024 shows a marked improvement, with ROA reaching 16.46%, before decreasing again to 7.52% in 2025. This volatility suggests the reported ROA is sensitive to changes in total assets and net income.
- Adjusted Return on Assets (ROA)
- Adjusted ROA exhibits a similar trend to the reported ROA, with a slight decrease from 13.61% in 2021 to 13.43% in 2022. A further decline to 11.55% is observed in 2023. The most significant increase occurs in 2024, with adjusted ROA reaching 22.99%, followed by a substantial decrease to 10.41% in 2025. The adjusted ROA consistently exceeds the reported ROA throughout the period, indicating that the inclusion of goodwill and intangible assets in the reported figures depresses the overall return.
The substantial increase in both reported and adjusted ROA in 2024, followed by a decline in 2025, warrants further investigation. The growing disparity between reported and adjusted asset values suggests that changes in goodwill and intangible assets significantly influence the reported financial performance. The adjusted ROA provides a potentially more representative view of operational efficiency by excluding these items.